nodes	percent_of_prediction	percent_of_DWPC	metapath
Azilsartan medoxomil—AGTR1—ACE Inhibitor Pathway—MAS1—glaucoma	0.048	0.235	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—ACE Inhibitor Pathway—ACE2—glaucoma	0.0364	0.178	CbGpPWpGaD
Azilsartan medoxomil—Hyperuricaemia—Diclofenamide—glaucoma	0.0236	0.0296	CcSEcCtD
Azilsartan medoxomil—Blood uric acid increased—Diclofenamide—glaucoma	0.0223	0.028	CcSEcCtD
Azilsartan medoxomil—Nausea—Physostigmine—glaucoma	0.0106	0.0134	CcSEcCtD
Azilsartan medoxomil—Connective tissue disorder—Latanoprost—glaucoma	0.00961	0.0121	CcSEcCtD
Azilsartan medoxomil—Hyperuricaemia—Betaxolol—glaucoma	0.00904	0.0114	CcSEcCtD
Azilsartan medoxomil—Muscle spasms—Carbachol—glaucoma	0.00896	0.0113	CcSEcCtD
Azilsartan medoxomil—Blood uric acid increased—Betaxolol—glaucoma	0.00854	0.0107	CcSEcCtD
Azilsartan medoxomil—AGTR1—ACE Inhibitor Pathway—NOS3—glaucoma	0.00801	0.0391	CbGpPWpGaD
Azilsartan medoxomil—Oedema peripheral—Apraclonidine—glaucoma	0.0077	0.00969	CcSEcCtD
Azilsartan medoxomil—Oedema peripheral—Bimatoprost—glaucoma	0.00747	0.00939	CcSEcCtD
Azilsartan medoxomil—Connective tissue disorder—Bimatoprost—glaucoma	0.00745	0.00937	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Latanoprost—glaucoma	0.0072	0.00905	CcSEcCtD
Azilsartan medoxomil—Angiopathy—Apraclonidine—glaucoma	0.00709	0.00892	CcSEcCtD
Azilsartan medoxomil—Angiopathy—Bimatoprost—glaucoma	0.00688	0.00865	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Latanoprost—glaucoma	0.00681	0.00857	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Latanoprost—glaucoma	0.00675	0.00849	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Diclofenamide—glaucoma	0.00673	0.00846	CcSEcCtD
Azilsartan medoxomil—Fatigue—Diclofenamide—glaucoma	0.00672	0.00845	CcSEcCtD
Azilsartan medoxomil—AGTR1—G alpha (q) signalling events—OPN4—glaucoma	0.00645	0.0315	CbGpPWpGaD
Azilsartan medoxomil—Connective tissue disorder—Travoprost—glaucoma	0.00627	0.00789	CcSEcCtD
Azilsartan medoxomil—Oedema peripheral—Brinzolamide—glaucoma	0.00621	0.00781	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Methazolamide—glaucoma	0.0062	0.00779	CcSEcCtD
Azilsartan medoxomil—Connective tissue disorder—Brinzolamide—glaucoma	0.00619	0.00779	CcSEcCtD
Azilsartan medoxomil—Fatigue—Methazolamide—glaucoma	0.00619	0.00778	CcSEcCtD
Azilsartan medoxomil—Asthenia—Metipranolol—glaucoma	0.00614	0.00772	CcSEcCtD
Azilsartan medoxomil—Angiopathy—Brimonidine—glaucoma	0.00609	0.00766	CcSEcCtD
Azilsartan medoxomil—Oedema peripheral—Pilocarpine—glaucoma	0.00597	0.0075	CcSEcCtD
Azilsartan medoxomil—AGTR1—G alpha (q) signalling events—PTGFR—glaucoma	0.00581	0.0284	CbGpPWpGaD
Azilsartan medoxomil—Angiopathy—Travoprost—glaucoma	0.00579	0.00728	CcSEcCtD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—OPN4—glaucoma	0.00577	0.0282	CbGpPWpGaD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Apraclonidine—glaucoma	0.00576	0.00724	CcSEcCtD
Azilsartan medoxomil—Angiopathy—Brinzolamide—glaucoma	0.00572	0.00719	CcSEcCtD
Azilsartan medoxomil—Asthenia—Carteolol—glaucoma	0.00569	0.00715	CcSEcCtD
Azilsartan medoxomil—Dizziness—Metipranolol—glaucoma	0.00566	0.00712	CcSEcCtD
Azilsartan medoxomil—Asthenia—Diclofenamide—glaucoma	0.00559	0.00703	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Bimatoprost—glaucoma	0.00558	0.00702	CcSEcCtD
Azilsartan medoxomil—Pruritus—Diclofenamide—glaucoma	0.00552	0.00694	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.00545	0.0266	CbGpPWpGaD
Azilsartan medoxomil—Nervous system disorder—Apraclonidine—glaucoma	0.00545	0.00685	CcSEcCtD
Azilsartan medoxomil—Rash—Metipranolol—glaucoma	0.0054	0.00679	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Apraclonidine—glaucoma	0.0054	0.00678	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Metipranolol—glaucoma	0.00539	0.00678	CcSEcCtD
Azilsartan medoxomil—Asthenia—Levobunolol—glaucoma	0.00538	0.00676	CcSEcCtD
Azilsartan medoxomil—Pruritus—Levobunolol—glaucoma	0.0053	0.00667	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Bimatoprost—glaucoma	0.00528	0.00664	CcSEcCtD
Azilsartan medoxomil—Muscle spasms—Brinzolamide—glaucoma	0.00528	0.00663	CcSEcCtD
Azilsartan medoxomil—Dizziness—Carteolol—glaucoma	0.00524	0.00659	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Bimatoprost—glaucoma	0.00523	0.00658	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Carbachol—glaucoma	0.00521	0.00655	CcSEcCtD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PTGFR—glaucoma	0.00519	0.0254	CbGpPWpGaD
Azilsartan medoxomil—Dizziness—Diclofenamide—glaucoma	0.00516	0.00648	CcSEcCtD
Azilsartan medoxomil—Asthenia—Methazolamide—glaucoma	0.00515	0.00648	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Levobunolol—glaucoma	0.00513	0.00645	CcSEcCtD
Azilsartan medoxomil—Angioedema—Dorzolamide—glaucoma	0.0051	0.00641	CcSEcCtD
Azilsartan medoxomil—Nausea—Metipranolol—glaucoma	0.00508	0.00639	CcSEcCtD
Azilsartan medoxomil—Muscle spasms—Pilocarpine—glaucoma	0.00507	0.00638	CcSEcCtD
Azilsartan medoxomil—Dizziness—Carbachol—glaucoma	0.00503	0.00633	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.00499	0.0244	CbGpPWpGaD
Azilsartan medoxomil—Dizziness—Levobunolol—glaucoma	0.00496	0.00623	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Brimonidine—glaucoma	0.00494	0.00621	CcSEcCtD
Azilsartan medoxomil—Pruritus—Latanoprost—glaucoma	0.00492	0.00618	CcSEcCtD
Azilsartan medoxomil—Rash—Diclofenamide—glaucoma	0.00492	0.00618	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Methazolamide—glaucoma	0.00491	0.00618	CcSEcCtD
Azilsartan medoxomil—Rash—Carbachol—glaucoma	0.0048	0.00603	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Apraclonidine—glaucoma	0.0048	0.00603	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Carbachol—glaucoma	0.00479	0.00603	CcSEcCtD
Azilsartan medoxomil—Fatigue—Apraclonidine—glaucoma	0.00479	0.00602	CcSEcCtD
Azilsartan medoxomil—Nausea—Carteolol—glaucoma	0.00471	0.00592	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Travoprost—glaucoma	0.0047	0.00591	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Brimonidine—glaucoma	0.00468	0.00588	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Bimatoprost—glaucoma	0.00465	0.00585	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Brinzolamide—glaucoma	0.00464	0.00583	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Brimonidine—glaucoma	0.00463	0.00583	CcSEcCtD
Azilsartan medoxomil—Nausea—Diclofenamide—glaucoma	0.00463	0.00582	CcSEcCtD
Azilsartan medoxomil—Dizziness—Latanoprost—glaucoma	0.0046	0.00578	CcSEcCtD
Azilsartan medoxomil—Rash—Methazolamide—glaucoma	0.00453	0.00569	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Methazolamide—glaucoma	0.00452	0.00569	CcSEcCtD
Azilsartan medoxomil—Nausea—Carbachol—glaucoma	0.00452	0.00568	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.00449	0.0219	CbGpPWpGaD
Azilsartan medoxomil—Nausea—Levobunolol—glaucoma	0.00445	0.0056	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Travoprost—glaucoma	0.00445	0.00559	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Travoprost—glaucoma	0.00441	0.00554	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Brinzolamide—glaucoma	0.00439	0.00552	CcSEcCtD
Azilsartan medoxomil—Angiopathy—Clonidine—glaucoma	0.00439	0.00552	CcSEcCtD
Azilsartan medoxomil—Rash—Latanoprost—glaucoma	0.00438	0.00551	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Latanoprost—glaucoma	0.00438	0.0055	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Brinzolamide—glaucoma	0.00435	0.00547	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Acetazolamide—glaucoma	0.00429	0.00539	CcSEcCtD
Azilsartan medoxomil—Fatigue—Acetazolamide—glaucoma	0.00428	0.00539	CcSEcCtD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.00427	0.0209	CbGpPWpGaD
Azilsartan medoxomil—Nausea—Methazolamide—glaucoma	0.00426	0.00536	CcSEcCtD
Azilsartan medoxomil—AGTR1—Angiopoietin receptor Tie2-mediated signaling—FN1—glaucoma	0.00425	0.0208	CbGpPWpGaD
Azilsartan medoxomil—Gastrointestinal disorder—Brimonidine—glaucoma	0.00412	0.00518	CcSEcCtD
Azilsartan medoxomil—Fatigue—Brimonidine—glaucoma	0.00411	0.00517	CcSEcCtD
Azilsartan medoxomil—Muscle spasms—Clonidine—glaucoma	0.00405	0.00509	CcSEcCtD
Azilsartan medoxomil—Asthenia—Apraclonidine—glaucoma	0.00399	0.00501	CcSEcCtD
Azilsartan medoxomil—Pruritus—Apraclonidine—glaucoma	0.00393	0.00494	CcSEcCtD
Azilsartan medoxomil—Fatigue—Dorzolamide—glaucoma	0.00393	0.00494	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Travoprost—glaucoma	0.00392	0.00492	CcSEcCtD
Azilsartan medoxomil—Fatigue—Travoprost—glaucoma	0.00391	0.00492	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Brinzolamide—glaucoma	0.00387	0.00486	CcSEcCtD
Azilsartan medoxomil—Asthenia—Bimatoprost—glaucoma	0.00386	0.00486	CcSEcCtD
Azilsartan medoxomil—Fatigue—Brinzolamide—glaucoma	0.00386	0.00485	CcSEcCtD
Azilsartan medoxomil—Angioedema—Clonidine—glaucoma	0.00385	0.00484	CcSEcCtD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.00385	0.0188	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—IL1A—glaucoma	0.00382	0.0187	CbGpPWpGaD
Azilsartan medoxomil—Angiopathy—Betaxolol—glaucoma	0.00382	0.0048	CcSEcCtD
Azilsartan medoxomil—Pruritus—Bimatoprost—glaucoma	0.00381	0.00479	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Apraclonidine—glaucoma	0.0038	0.00478	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Pilocarpine—glaucoma	0.00372	0.00467	CcSEcCtD
Azilsartan medoxomil—Dizziness—Apraclonidine—glaucoma	0.00367	0.00462	CcSEcCtD
Azilsartan medoxomil—AGTR1—Angiopoietin receptor Tie2-mediated signaling—MMP2—glaucoma	0.00361	0.0176	CbGpPWpGaD
Azilsartan medoxomil—Asthenia—Acetazolamide—glaucoma	0.00357	0.00448	CcSEcCtD
Azilsartan medoxomil—Dizziness—Bimatoprost—glaucoma	0.00356	0.00448	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.00356	0.00448	CcSEcCtD
Azilsartan medoxomil—Muscle spasms—Betaxolol—glaucoma	0.00352	0.00443	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Apraclonidine—glaucoma	0.0035	0.0044	CcSEcCtD
Azilsartan medoxomil—Asthenia—Brimonidine—glaucoma	0.00342	0.0043	CcSEcCtD
Azilsartan medoxomil—AGTR1—Allograft Rejection—FAS—glaucoma	0.00341	0.0166	CbGpPWpGaD
Azilsartan medoxomil—Diarrhoea—Acetazolamide—glaucoma	0.0034	0.00428	CcSEcCtD
Azilsartan medoxomil—Rash—Bimatoprost—glaucoma	0.0034	0.00427	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Bimatoprost—glaucoma	0.00339	0.00427	CcSEcCtD
Azilsartan medoxomil—Oedema peripheral—Timolol—glaucoma	0.00339	0.00426	CcSEcCtD
Azilsartan medoxomil—Connective tissue disorder—Timolol—glaucoma	0.00338	0.00425	CcSEcCtD
Azilsartan medoxomil—AGTR1—Angiopoietin receptor Tie2-mediated signaling—NOS3—glaucoma	0.00338	0.0165	CbGpPWpGaD
Azilsartan medoxomil—Pruritus—Brimonidine—glaucoma	0.00337	0.00424	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Clonidine—glaucoma	0.00337	0.00424	CcSEcCtD
Azilsartan medoxomil—AGTR1—Allograft Rejection—C3—glaucoma	0.00336	0.0164	CbGpPWpGaD
Azilsartan medoxomil—Skin disorder—Clonidine—glaucoma	0.00334	0.0042	CcSEcCtD
Azilsartan medoxomil—Nausea—Apraclonidine—glaucoma	0.0033	0.00415	CcSEcCtD
Azilsartan medoxomil—Dizziness—Acetazolamide—glaucoma	0.00329	0.00413	CcSEcCtD
Azilsartan medoxomil—Asthenia—Dorzolamide—glaucoma	0.00327	0.00411	CcSEcCtD
Azilsartan medoxomil—Asthenia—Travoprost—glaucoma	0.00325	0.00409	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—OPN4—glaucoma	0.00325	0.0159	CbGpPWpGaD
Azilsartan medoxomil—Pruritus—Dorzolamide—glaucoma	0.00322	0.00405	CcSEcCtD
Azilsartan medoxomil—Asthenia—Brinzolamide—glaucoma	0.00321	0.00404	CcSEcCtD
Azilsartan medoxomil—Pruritus—Travoprost—glaucoma	0.00321	0.00403	CcSEcCtD
Azilsartan medoxomil—Nausea—Bimatoprost—glaucoma	0.0032	0.00402	CcSEcCtD
Azilsartan medoxomil—Pruritus—Brinzolamide—glaucoma	0.00317	0.00398	CcSEcCtD
Azilsartan medoxomil—Dizziness—Brimonidine—glaucoma	0.00315	0.00397	CcSEcCtD
Azilsartan medoxomil—Angiopathy—Timolol—glaucoma	0.00312	0.00393	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Dorzolamide—glaucoma	0.00312	0.00392	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Travoprost—glaucoma	0.0031	0.0039	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.0031	0.0039	CcSEcCtD
Azilsartan medoxomil—Asthenia—Pilocarpine—glaucoma	0.00309	0.00388	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Brinzolamide—glaucoma	0.00306	0.00385	CcSEcCtD
Azilsartan medoxomil—Pruritus—Pilocarpine—glaucoma	0.00304	0.00383	CcSEcCtD
Azilsartan medoxomil—Dizziness—Dorzolamide—glaucoma	0.00301	0.00379	CcSEcCtD
Azilsartan medoxomil—Rash—Brimonidine—glaucoma	0.00301	0.00378	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Brimonidine—glaucoma	0.003	0.00378	CcSEcCtD
Azilsartan medoxomil—Dizziness—Travoprost—glaucoma	0.003	0.00377	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Clonidine—glaucoma	0.00297	0.00373	CcSEcCtD
Azilsartan medoxomil—Fatigue—Clonidine—glaucoma	0.00296	0.00373	CcSEcCtD
Azilsartan medoxomil—Dizziness—Brinzolamide—glaucoma	0.00296	0.00372	CcSEcCtD
Azilsartan medoxomil—Nausea—Acetazolamide—glaucoma	0.00295	0.00371	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Pilocarpine—glaucoma	0.00294	0.0037	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Betaxolol—glaucoma	0.00293	0.00369	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—PTGFR—glaucoma	0.00293	0.0143	CbGpPWpGaD
Azilsartan medoxomil—Skin disorder—Betaxolol—glaucoma	0.00291	0.00365	CcSEcCtD
Azilsartan medoxomil—Rash—Dorzolamide—glaucoma	0.00287	0.00361	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Dorzolamide—glaucoma	0.00287	0.00361	CcSEcCtD
Azilsartan medoxomil—Rash—Travoprost—glaucoma	0.00286	0.0036	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Travoprost—glaucoma	0.00286	0.00359	CcSEcCtD
Azilsartan medoxomil—Dizziness—Pilocarpine—glaucoma	0.00285	0.00358	CcSEcCtD
Azilsartan medoxomil—Nausea—Brimonidine—glaucoma	0.00283	0.00356	CcSEcCtD
Azilsartan medoxomil—Rash—Brinzolamide—glaucoma	0.00282	0.00355	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Brinzolamide—glaucoma	0.00282	0.00355	CcSEcCtD
Azilsartan medoxomil—Angioedema—Timolol—glaucoma	0.00274	0.00344	CcSEcCtD
Azilsartan medoxomil—Rash—Pilocarpine—glaucoma	0.00271	0.00341	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Pilocarpine—glaucoma	0.00271	0.00341	CcSEcCtD
Azilsartan medoxomil—Nausea—Dorzolamide—glaucoma	0.00271	0.0034	CcSEcCtD
Azilsartan medoxomil—Nausea—Travoprost—glaucoma	0.00269	0.00339	CcSEcCtD
Azilsartan medoxomil—Nausea—Brinzolamide—glaucoma	0.00266	0.00334	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Betaxolol—glaucoma	0.00258	0.00325	CcSEcCtD
Azilsartan medoxomil—Fatigue—Betaxolol—glaucoma	0.00258	0.00324	CcSEcCtD
Azilsartan medoxomil—Nausea—Pilocarpine—glaucoma	0.00256	0.00321	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.00253	0.00318	CcSEcCtD
Azilsartan medoxomil—Asthenia—Clonidine—glaucoma	0.00247	0.0031	CcSEcCtD
Azilsartan medoxomil—Pruritus—Clonidine—glaucoma	0.00243	0.00306	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Timolol—glaucoma	0.0024	0.00301	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Timolol—glaucoma	0.00237	0.00299	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Clonidine—glaucoma	0.00235	0.00296	CcSEcCtD
Azilsartan medoxomil—Dizziness—Clonidine—glaucoma	0.00227	0.00286	CcSEcCtD
Azilsartan medoxomil—Rash—Clonidine—glaucoma	0.00217	0.00272	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Clonidine—glaucoma	0.00217	0.00272	CcSEcCtD
Azilsartan medoxomil—Asthenia—Betaxolol—glaucoma	0.00215	0.0027	CcSEcCtD
Azilsartan medoxomil—Pruritus—Betaxolol—glaucoma	0.00212	0.00266	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Timolol—glaucoma	0.00211	0.00265	CcSEcCtD
Azilsartan medoxomil—Fatigue—Timolol—glaucoma	0.00211	0.00265	CcSEcCtD
Azilsartan medoxomil—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—glaucoma	0.00209	0.0102	CbGpPWpGaD
Azilsartan medoxomil—Diarrhoea—Betaxolol—glaucoma	0.00205	0.00257	CcSEcCtD
Azilsartan medoxomil—Nausea—Clonidine—glaucoma	0.00204	0.00257	CcSEcCtD
Azilsartan medoxomil—Dizziness—Betaxolol—glaucoma	0.00198	0.00249	CcSEcCtD
Azilsartan medoxomil—AGTR1—G alpha (q) signalling events—EDN1—glaucoma	0.00193	0.00943	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—EDN1—glaucoma	0.00191	0.00931	CbGpPWpGaD
Azilsartan medoxomil—Rash—Betaxolol—glaucoma	0.00189	0.00237	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Betaxolol—glaucoma	0.00188	0.00237	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—OPN4—glaucoma	0.00184	0.00898	CbGpPWpGaD
Azilsartan medoxomil—Nausea—Betaxolol—glaucoma	0.00178	0.00223	CcSEcCtD
Azilsartan medoxomil—Asthenia—Timolol—glaucoma	0.00175	0.00221	CcSEcCtD
Azilsartan medoxomil—Pruritus—Timolol—glaucoma	0.00173	0.00217	CcSEcCtD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	0.00173	0.00843	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—VEGFA—glaucoma	0.00169	0.00825	CbGpPWpGaD
Azilsartan medoxomil—Diarrhoea—Timolol—glaucoma	0.00167	0.0021	CcSEcCtD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—OPN4—glaucoma	0.00167	0.00815	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—C3—glaucoma	0.00167	0.00813	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—PTGFR—glaucoma	0.00166	0.00808	CbGpPWpGaD
Azilsartan medoxomil—Dizziness—Timolol—glaucoma	0.00162	0.00203	CcSEcCtD
Azilsartan medoxomil—Rash—Timolol—glaucoma	0.00154	0.00194	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Timolol—glaucoma	0.00154	0.00194	CcSEcCtD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—PTGFR—glaucoma	0.0015	0.00734	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—SMO—glaucoma	0.00148	0.00721	CbGpPWpGaD
Azilsartan medoxomil—Nausea—Timolol—glaucoma	0.00145	0.00183	CcSEcCtD
Azilsartan medoxomil—AGTR1—Allograft Rejection—TNF—glaucoma	0.00145	0.00707	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—LRP12—glaucoma	0.00142	0.00695	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.00128	0.00625	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.00112	0.00546	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—OPN4—glaucoma	0.000986	0.00482	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—EDN1—glaucoma	0.000974	0.00476	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—HEYL—glaucoma	0.000917	0.00448	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PTGFR—glaucoma	0.000888	0.00434	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—C3—glaucoma	0.000851	0.00415	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—SMO—glaucoma	0.000758	0.0037	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—RPTOR—glaucoma	0.000695	0.00339	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NCK2—glaucoma	0.000673	0.00329	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—HDAC9—glaucoma	0.000572	0.00279	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—EDN1—glaucoma	0.00055	0.00269	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—EDN1—glaucoma	0.0005	0.00244	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—C3—glaucoma	0.000481	0.00235	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—SMO—glaucoma	0.000448	0.00219	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—C3—glaucoma	0.000436	0.00213	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NTRK2—glaucoma	0.000409	0.002	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NGFR—glaucoma	0.000351	0.00172	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NTRK1—glaucoma	0.000334	0.00163	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CDKN2B—glaucoma	0.000308	0.0015	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—EDN1—glaucoma	0.000295	0.00144	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NGF—glaucoma	0.000271	0.00132	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—C3—glaucoma	0.000258	0.00126	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—APOE—glaucoma	0.00024	0.00117	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CAV1—glaucoma	0.000238	0.00116	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—FN1—glaucoma	0.000226	0.00111	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—BAD—glaucoma	0.000224	0.00109	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NOS3—glaucoma	0.00018	0.000878	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CDKN1B—glaucoma	0.000156	0.000761	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—MMP9—glaucoma	0.000144	0.000705	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—VEGFA—glaucoma	0.00013	0.000633	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—TP53—glaucoma	9.79e-05	0.000478	CbGpPWpGaD
